Market Research Logo

The Spectranetics Corporation (SPNC) - Product Pipeline Analysis, 2016 Update

Summary

The Spectranetics Corporation (Spectranetics) is a medical device company that manufactures, commercializes and distributes disposable medical devices. The company offers vascular intervention, lead management and coronary intervention products. It manufactures and sells a range of peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries. Spectranetics also offers coronary laser atherectomy catheters, scoring balloon catheter, excimer laser system, extraction catheter and support catheters. The company offers training and support services. It caters to physicians, patients and hospitals. The company has presence in the Netherlands, France, Denmark, Germany, Austria, Australia and the UK. Spectranetics is headquartered in Colorado Springs, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company The Spectranetics Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


The Spectranetics Corporation Company Snapshot
The Spectranetics Corporation Company Overview
The Spectranetics Corporation Pipeline Products and Clinical Trials Overview
The Spectranetics Corporation – Pipeline Analysis Overview
Key Facts
The Spectranetics Corporation - Major Products and Services
The Spectranetics Corporation Pipeline Products by Development Stage
The Spectranetics Corporation Clinical Trials by Trial Status
The Spectranetics Corporation Pipeline Products Overview
CardioSculpt Valvuloplasty Scoring Balloon
CardioSculpt Valvuloplasty Scoring Balloon Product Overview
Drug Coated Balloon - In-stent Restenosis (ISR)
Drug Coated Balloon - In-stent Restenosis (ISR) Product Overview
Next Gen Lead Management (LM) Tool
Next Gen Lead Management (LM) Tool Product Overview
Next Generation Excimer Laser System
Next Generation Excimer Laser System Product Overview
Next-Gen Atherectomy Device
Next-Gen Atherectomy Device Product Overview
Next-gen Mechanical Tool
Next-gen Mechanical Tool Product Overview
Stellarex Drug Coated Balloon - Below The Knee (BTK)
Stellarex Drug Coated Balloon - Below The Knee (BTK) Product Overview
Stellarex Drug Coated Balloon - Superficial Femoral Artery
Stellarex Drug Coated Balloon - Superficial Femoral Artery Product Overview
Stellarex Drug Coated Balloon - Superficial Femoral Artery Clinical Trial
The Spectranetics Corporation - Key Competitors
The Spectranetics Corporation - Key Employees
The Spectranetics Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
The Spectranetics Corporation, Recent Developments
Aug 10, 2016: First Randomized Trial of the Stellarex Drug-coated Balloon Presented at the Amputation Prevention Symposium
Aug 10, 2016: Spectranetics Receives CE Mark for AngioSculptX
Jul 28, 2016: Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million
Jul 25, 2016: QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment
Jul 21, 2016: Federal Circuit Court Rules in Appeal
Jul 20, 2016: 12-month Results of the ILLUMENATE European Randomized Clinical Trial to be Presented at the Amputation Prevention Symposium
Jun 01, 2016: Second Interim Analysis on ILLUMENATE Global Study Presented on Spectranetics’ Stellarex drug-coated balloon at NCVH
Apr 28, 2016: Spectranetics Achieves First Quarter 2016 Revenue of $62.9 million
Apr 26, 2016: 12-Month Interim ILLUMENATE Global Study Data Presented on Spectranetics’ Stellarex drug-coated balloon at Charing Cross
Mar 24, 2016: Spectranetics Names Udo Scheiner as Senior Vice President, International Operations
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
The Spectranetics Corporation Pipeline Products and Clinical Trials Overview
The Spectranetics Corporation Pipeline Products by Equipment Type
The Spectranetics Corporation Pipeline Products by Indication
The Spectranetics Corporation Clinical Trials by Trial Status
The Spectranetics Corporation, Key Facts
The Spectranetics Corporation, Major Products and Services
The Spectranetics Corporation Number of Pipeline Products by Development Stage
The Spectranetics Corporation Pipeline Products Summary by Development Stage
The Spectranetics Corporation Clinical Trials by Trial Status
The Spectranetics Corporation Clinical Trials Summary
CardioSculpt Valvuloplasty Scoring Balloon - Product Status
CardioSculpt Valvuloplasty Scoring Balloon - Product Description
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description
Next Gen Lead Management (LM) Tool - Product Status
Next Gen Lead Management (LM) Tool - Product Description
Next Generation Excimer Laser System - Product Status
Next Generation Excimer Laser System - Product Description
Next-Gen Atherectomy Device - Product Status
Next-Gen Atherectomy Device - Product Description
Next-gen Mechanical Tool - Product Status
Next-gen Mechanical Tool - Product Description
Stellarex Drug Coated Balloon - Below The Knee (BTK) - Product Status
Stellarex Drug Coated Balloon - Below The Knee (BTK) - Product Description
Stellarex Drug Coated Balloon - Superficial Femoral Artery - Product Status
Stellarex Drug Coated Balloon - Superficial Femoral Artery - Product Description
Stellarex Drug Coated Balloon - Superficial Femoral Artery - ILLUMENATE First-in-Human (FIH) Study on the Safety and Effectiveness of Covidien’s Advanced Drug-coated Balloon (DCB) Technology
Stellarex Drug Coated Balloon - Superficial Femoral Artery - Prospective, Single-arm, Global Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery and/or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon (ILLUMENATE GLOBAL)
Stellarex Drug Coated Balloon - Superficial Femoral Artery - Prospective, Single-arm, Multi-center, Pharmacokinetic Study to Evaluate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon
Stellarex Drug Coated Balloon - Superficial Femoral Artery - Stellarex Vascular E-Registry
The Spectranetics Corporation, Key Employees
The Spectranetics Corporation, Other Locations
The Spectranetics Corporation, Subsidiaries
List of Figures
The Spectranetics Corporation Pipeline Products by Equipment Type
The Spectranetics Corporation Pipeline Products by Development Stage
The Spectranetics Corporation Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report